Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Stockholders' Equity

v3.25.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Treasury Stock, Common [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Additional Paid-in Capital [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
AOCI Attributable to Parent [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Unallocated Common Share Held By ESOP [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock Outstanding [Member]
Common Stock [Member]
Treasury Stock, Common [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Unallocated Common Share Held By ESOP [Member]
Total
Balance (in shares) at Dec. 31, 2022               5,397,959              
Balance (Accounting Standards Update 2016-13 [Member]) at Dec. 31, 2022 $ 0 $ 0 $ 0 $ (279) $ 0 $ 0 $ (279)                
Balance at Dec. 31, 2022                 $ 54 $ 0 $ 50,420 $ 45,291 $ (11,125) $ (4,098) $ 80,542
Net loss                 0 0 0 (3,957) 0 0 (3,957)
ESOP shares committed to be released                 0 0 (17) 0 0 216 199
Purchase of treasury stock from stock repurchase program (in shares)               (269,898)              
Purchase of treasury stock from stock repurchase program                 0 (2,381) 0 0 0 0 (2,381)
Compensation cost for stock options and restricted stock                 0 0 519 0 0 0 519
Issuance of common shares for the restricted stock plan (in shares)               187,200              
Issuance of common shares for the restricted stock plan                 2 0 (2) 0 0 0 0
Change in net unrealized gain on securities available for sale, net                 0 0 0 0 2,902 0 2,902
Balance (in shares) at Dec. 31, 2023               5,315,261              
Net loss                 0 0 0 (3,957) 0 0 (3,957)
Purchase of treasury stock from stock repurchase program (in shares)               269,898              
Balance at Dec. 31, 2023                 56 (2,381) 50,920 41,055 (8,223) (3,882) 77,545
Net loss                 0 0 0 (789) 0 0 (789)
ESOP shares committed to be released                 0 0 2 0 0 212 214
Purchase of treasury stock from stock repurchase program (in shares)               93,732              
Purchase of treasury stock from stock repurchase program                 0 (970) 0 0 0 0 (970)
Compensation cost for stock options and restricted stock                 0 0 767 0 0 0 767
Issuance of common shares for the restricted stock plan (in shares)               16,700              
Issuance of common shares for the restricted stock plan                 0 0 0 0 0 0 0
Change in net unrealized gain on securities available for sale, net                 0 0 0 0 (383) 0 (383)
Balance (in shares) at Dec. 31, 2024               5,249,826              
Net loss                 0 0 0 (789) 0 0 (789)
Purchase of treasury stock from stock repurchase program (in shares)               (93,732)              
Purchase of treasury stock from taxes withheld on net share settlement of restricted stock awards (in shares)               (11,403)              
Purchase of treasury stock from taxes withheld on net share settlement of restricted stock awards                 0 (109) 0 0 0 0 (109)
Reissuance of treasury stock for options exercised (in shares)               23,000              
Reissuance of treasury stock for options exercised                 0 220 (5) 0 0 0 215
Balance at Dec. 31, 2024                 $ 56 $ (3,240) $ 51,684 $ 40,266 $ (8,606) $ (3,670) $ 76,490